Xenical (orlistat) helped obese adolescents reduce weight, but this first major study of the drug for kids in this age group carried some unwelcome gastrointestinal baggage.
A multi-center trial published in the June 15 issue of Journal of the American Medical Association suggested that Xenical, combined with diet, exercise, and behavioral therapy, could be a promising […]
America’s growing number of diabetics have reason to be excited. German doctors presented a new transdermal insulin delivery system at the American Diabetes Association 65th Annual Scientific Sessions.
While this method holds great promise to rid diabetes sufferers of the need to inject insulin on a daily basis, there are still some issues […]
“The FDA has accepted Lorus’ proposal for a rolling submission for its new drug application for Virulizin, the company’s lead anticancer drug for the treatment of pancreatic cancer.
“The agreement comes after Lorus met with the FDA on May 25, 2005 to discuss the chemistry, manufacturing, controls (quality) and non-clinical data packages that it plans to […]
“A company based in Melbourne, Austrailia has discovered that a toxin produced by the cone snail has the potential for easing pain and could provide an improved treatment for neuropathic pain associated with diabetes.
“During preclinical trials of the toxin, now called ACV1, researchers from Metabolic Pharmaceuticals found it not only to be effective in treating […]
“Advancis Pharmaceutical has launched an oral formulation of the respiratory tract infection drug Keflex in the US.
“Keflex is approved for treatment of respiratory tract infections caused by S. pneumoniae and S. pyogenes; otitis media due to S. pneumoniae, H. influenzae, and M. catarrhalis; and skin and soft tissue infections due to staphylococci and/or streptococci as […]
“Research by Bristol-Myers Squibb has found that the company’s investigational drug abatacept could slow the progression of joint damage in patients with active rheumatoid arthritis.
“Abatacept is an investigational selective co-stimulation modulator, which, according to new findings from a recent phase III clinical trial, is affective against arthritus independent of baseline clinical, biochemical, or radiographic characteristics.”
Read […]
“The safety of one of the world’s most popular painkillers was called into question yesterday for the second time in days.
“A new study lists ibuprofen as one of a number of anti-inflammatory drugs which may increase the risk of heart attacks. Another study earlier linked both ibuprofen, widely used for headaches and arthritis, and aspirin […]
“The discovery of a fourth patient who may have developed a life-threatening brain infection after taking the multiple sclerosis drug Tysabri raises worries that the drug is more dangerous than previously thought.
“If the fourth case of the normally extremely rare infection is confirmed, it would make it more difficult for the drug to return to […]
“Affymax has received positive preclinical data and phase I study results for its lead product candidate, Hematide, indicating that it is well tolerated and able to raise red blood cell production necessary for the treatment of anemia.
“Hematide is a peptide-based erythropoiesis stimulating agent (ESA) being developed for the treatment of anemia in patients with chronic […]
“A recent study published in the American Journal of Clinical Nutrition shows that eating certain foods can lower your cholesterol levels just as well as taking statin drugs.
“This is the second study we’ve seen revealing that certain foods are as effective, or even more effective, than prescription drugs in regulating biochemical markers such as cholesterol […]